Sign up for our Oncology Central weekly news round-up

Biomarker could help identify patients at high risk of lung cancer metastasis

Written by Heather Jones, Future Science Group

Researchers from Tulane University (LA, USA) have identified a protein that could indicate whether a non-small cell lung cancer (NSCLC) tumor is likely to metastasize, according to a new study in Science Advances. The protein, present on tumor-derived extracellular vesicles, could be used as a biomarker for a test to potentially uncover these cancers earlier when they are more treatable.  Non-small cell lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death worldwide, with more than half of NSCLC patients dying after their cancer has spread. No two cancers are the same, even patients diagnosed...

To view this content, please register now for access

It's completely free